1. Home
  2. QNCX vs MBOT Comparison

QNCX vs MBOT Comparison

Compare QNCX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • MBOT
  • Stock Information
  • Founded
  • QNCX 2012
  • MBOT 2010
  • Country
  • QNCX United States
  • MBOT United States
  • Employees
  • QNCX 36
  • MBOT N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • MBOT Medical/Dental Instruments
  • Sector
  • QNCX Health Care
  • MBOT Health Care
  • Exchange
  • QNCX Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • QNCX 139.2M
  • MBOT 128.9M
  • IPO Year
  • QNCX 2019
  • MBOT N/A
  • Fundamental
  • Price
  • QNCX $2.68
  • MBOT $1.91
  • Analyst Decision
  • QNCX Strong Buy
  • MBOT Strong Buy
  • Analyst Count
  • QNCX 4
  • MBOT 1
  • Target Price
  • QNCX $7.75
  • MBOT $12.00
  • AVG Volume (30 Days)
  • QNCX 551.1K
  • MBOT 1.9M
  • Earning Date
  • QNCX 11-12-2025
  • MBOT 11-12-2025
  • Dividend Yield
  • QNCX N/A
  • MBOT N/A
  • EPS Growth
  • QNCX N/A
  • MBOT N/A
  • EPS
  • QNCX N/A
  • MBOT N/A
  • Revenue
  • QNCX N/A
  • MBOT N/A
  • Revenue This Year
  • QNCX N/A
  • MBOT N/A
  • Revenue Next Year
  • QNCX N/A
  • MBOT $1,107.73
  • P/E Ratio
  • QNCX N/A
  • MBOT N/A
  • Revenue Growth
  • QNCX N/A
  • MBOT N/A
  • 52 Week Low
  • QNCX $0.72
  • MBOT $0.93
  • 52 Week High
  • QNCX $2.85
  • MBOT $4.67
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 83.72
  • MBOT 36.04
  • Support Level
  • QNCX $1.61
  • MBOT $1.70
  • Resistance Level
  • QNCX $1.84
  • MBOT $2.20
  • Average True Range (ATR)
  • QNCX 0.21
  • MBOT 0.13
  • MACD
  • QNCX 0.10
  • MBOT 0.02
  • Stochastic Oscillator
  • QNCX 87.94
  • MBOT 40.40

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.

Share on Social Networks: